BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36535912)

  • 1. Psychometric Performance of the SF-6D Quality of Life Measure in an Outpatient Population with Bipolar Disorder.
    Pogue YZ; Lavelle TA; Hodgkin D; Sylvia L; Ritter G; Nierenberg A
    J Ment Health Policy Econ; 2022 Dec; 25(4):143-150. PubMed ID: 36535912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures.
    Brazier J; Connell J; Papaioannou D; Mukuria C; Mulhern B; Peasgood T; Jones ML; Paisley S; O'Cathain A; Barkham M; Knapp M; Byford S; Gilbody S; Parry G
    Health Technol Assess; 2014 May; 18(34):vii-viii, xiii-xxv, 1-188. PubMed ID: 24857402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.
    Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D;
    Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer.
    Bulamu NB; Mpundu-Kaambwa C; O'Callaghan M; Kaambwa B
    BMC Cancer; 2023 Apr; 23(1):297. PubMed ID: 37005587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D.
    Stolz M; Albus C; Beutel ME; Deter HC; Fritzsche K; Herrmann-Lingen C; Michal M; Petrowski K; Ronel J; Schultz JH; Söllner W; Weber C; de Zwaan M; Krauth C
    Eur J Health Econ; 2023 Nov; 24(8):1297-1307. PubMed ID: 36385438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
    Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
    Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring psychometric properties of the SF-6D, a preference-based health-related quality of life measure, in the context of spinal cord injury.
    Engel L; Bryan S; Evers SM; Dirksen CD; Noonan VK; Whitehurst DG
    Qual Life Res; 2014 Oct; 23(8):2383-93. PubMed ID: 24700379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population.
    McDool E; Mukuria C; Brazier J
    Pharmacoeconomics; 2021 Aug; 39(8):929-940. PubMed ID: 34043147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in Iranian patients with bipolar disorder: a psychometric study of the Persian Brief Quality of Life in Bipolar Disorder (QoL.BD).
    Modabbernia A; Yaghoubidoust M; Lin CY; Fridlund B; Michalak EE; Murray G; Pakpour AH
    Qual Life Res; 2016 Jul; 25(7):1835-44. PubMed ID: 26714698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of patient-reported outcome measures in individuals following acute whiplash injury.
    Pink J; Petrou S; Williamson E; Williams M; Lamb SE
    Health Qual Life Outcomes; 2014 Mar; 12():38. PubMed ID: 24625124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the five-level EuroQoL-5 dimension and Short Form-6 dimension measures of health-related quality of life in a population of pregnant women with depression.
    Heslin M; Chua KC; Trevillion K; Nath S; Howard LM; Byford S
    BJPsych Open; 2019 Oct; 5(6):e88. PubMed ID: 31588885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D.
    Mulhern B; Pink J; Rowen D; Borghs S; Butt T; Hughes D; Marson A; Brazier J
    Value Health; 2017 Apr; 20(4):687-693. PubMed ID: 28408012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore.
    Abdin E; Chong SA; Seow E; Peh CX; Tan JH; Liu J; Hui SFS; Chua BY; Sim K; Verma S; Vaingankar JA; Subramaniam M
    Psychiatry Res; 2019 Apr; 274():400-408. PubMed ID: 30852434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the Performance of 2 Health Utility Measures in the Medicare Health Outcome Survey (HOS).
    Jia H; Lubetkin EI; DeMichele K; Stark DS; Zack MM; Thompson WW
    Med Decis Making; 2018 Nov; 38(8):983-993. PubMed ID: 30403580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.